Tumor suppressive activity of anti-CD274 antibody as an immune checkpoint inhibitor for cervical cancer mouse model

被引：0
|
作者：
Murakami, Kazuyuki [1 ]
Yoshino, Naoto [2 ]
Kawamura, Hanae [1 ]
Sasaki, Yutaka [2 ]
Kagabu, Masahiro [1 ]
Muraki, Yasushi [2 ]
Sugiyama, Toru [1 ]
机构：
[1] Iwate Med Univ, Sch Med, Dept Obstet & Gynecol, Morioka, Iwate, Japan
[2] Iwate Med Univ, Sch Med, Div Infect Dis & Immunol, Dept Microbiol, Morioka, Iwate, Japan
来源：
JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 2015年 / 112卷
关键词：
D O I：
10.1016/j.jri.2015.09.059
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
56
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [31] Immune checkpoint inhibitor (anti PD-1/PD-L1 antibody activity in dedifferentiated endometrial carcinoma.
    Ono, Ruriko
    Nakayama, Kentaro
    Itamochi, Hiroaki
    Nakamura, Kohei
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Ohnishi, Kaori
    Minamoto, Toshiko
    Iida, Kouji
    Ishikawa, Noriyoshi
    Otsuki, Yoshiro
    Kyo, Satoru
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] IL-9 stimulates an anti-tumor immune response and facilitates immune checkpoint blockade in the CMT167 mouse model
    Feng, Yuqian
    Yan, Sheng
    Lam, Sze Kwan
    Ko, Frankie Chi Fat
    Chen, Caoyang
    Khan, Mahjabin
    Ho, James Chung-Man
    LUNG CANCER, 2022, 174 : 14 - 26
  • [33] Robust anti-tumor effects of combined anti-CD4 depleting antibody and anti-PD-1/PD-L1 immune checkpoint antibody treatment in mice
    Ito, Satoru
    Matsushima, Kouji
    Ueha, Satoshi
    Yokochi, Shoji
    Ishiwata, Yoshiro
    Hachiga, Kosuke
    Ogiwara, Haru
    Chand, Krishant
    Nakajima, Takumi
    CANCER RESEARCH, 2015, 75
  • [34] Targeting Tumor Cells with Anti-CD44 Antibody Triggers Macrophage-Mediated Immune Modulatory Effects in a Cancer Xenograft Model
    Maisel, Daniela
    Birzele, Fabian
    Voss, Edgar
    Nopora, Adam
    Bader, Sabine
    Friess, Thomas
    Goller, Bernhard
    Laifenfeld, Daphna
    Weigand, Stefan
    Runza, Valeria
    PLOS ONE, 2016, 11 (07):
  • [35] Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model
    Kendrick, James E.
    Straughn, J. Michael, Jr.
    Oliver, Patsy G.
    Wang, Wenquan
    Nan, Li
    Grizzle, William E.
    Stockard, Cecil R.
    Alvarez, Ronald D.
    Buchsbaum, Donald J.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : 591 - 597
  • [36] Cytotopically modified antibodies to checkpoint proteins can actively reconstitute immune checkpoint blockade and inhibit tumor growth in a prostate cancer mouse model
    Smoiarek, Dorota
    Sakellariou, Christina A.
    Dasgupta, Prokar
    Smith, Richard A. G.
    Galustian, Christine
    CANCER RESEARCH, 2015, 75
  • [37] The tyrosine kinase inhibitor XL092 promotes an immune-permissive tumor microenvironment and enhances the anti-tumor activity of immune checkpoint inhibitors in preclinical models
    Hsu, Jeff
    Chong, Colin
    Serrill, Jeffrey
    Wu, Sharon
    Leong, Kevin
    Yun, Ted
    Bannen, Lynne
    Lamb, Peter
    Xu, Wei
    Yu, Peiwen
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [38] Cordycepin enhances anti-tumor immunity in colon cancer by inhibiting phagocytosis immune checkpoint CD47 expression
    Deng, Qifeng
    Li, Xinrui
    Fang, Chunqiang
    Li, Xin
    Zhang, Jing
    Xi, Qing
    Li, Yan
    Zhang, Rongxin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 107
  • [39] Checkpoint inhibitor therapy in combination with the implantation of agarose encapsulated cancer cells inhibits tumor growth in a mouse model of osteosarcoma
    Dumpala, Pradeep R.
    Martis, Prithy C.
    Bemrose, Melissa A.
    Dudley, Atira
    Smith, Barry H.
    Gazda, Lawrence S.
    CANCER RESEARCH, 2018, 78 (13)
  • [40] Anti-KIT Monoclonal Antibody Treatment Enhances the Antitumor Activity of Immune Checkpoint Inhibitors by Reversing Tumor-Induced Immunosuppression
    Garton, Andrew J.
    Seibel, Scott
    Lopresti-Morrow, Lori
    Crew, Linda
    Janson, Neal
    Mandiyan, Sreekala
    Trombetta, E. Sergio
    Pankratz, Shannon
    LaVallee, Theresa M.
    Gedrich, Richard
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (04) : 671 - 680
12345